Terremoto Biosciences, Inc., 2026-04-22
An SEC Form D private-offering notice from South San Francisco, CA, a $108,599,999 filer-stated offering target in Biotech. Filed 2026-04-22. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotech developing selective covalent AKT1 inhibitors for oncology and hereditary hemorrhagic telangiectasia; recently closed a $108 million Series C.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- SCIENCE LAB 3, INC., 2026-04-22, $11.1M, Dana Point, CA
- Corami Biotech Inc., 2026-04-22, $1M, Memphis, TN
- FOCUS UNIVERSAL INC., 2026-04-22, $4M, West Covina, CA
- Tetrous, Inc., 2026-04-22, $4M, Sherman Oaks, CA
- Personalized Beauty Discovery, Inc., 2026-04-22, Santa Monica, CA
- Hepion Pharmaceuticals, Inc., 2026-04-22, $700K, Red Bank, NJ
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.